Medios: H1 including Ceban acquisition, reconfirmed outlook
Medios reported H1 2024 results with revenue increasing 6.3% YoY to EUR 907.3m slightly below our estimates of EUR 920m. We appreciate the positive development of the Pharmaceutical Supply (PS) segment sales which grew by 7.3% YoY to EUR 787.9m, however, Q2 came ~4% QoQ lower. Similarly, the softerMedios AG. Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.